Literature DB >> 7004155

Cardioversion and defibrillation.

R A DeSilva, T B Graboys, P J Podrid, B Lown.   

Abstract

The use of electrical energy for the immediate treatment of atrial and ventricular arrhythmias is practical and easily applied. The method, though simple, is the most effective method for terminating cardiac arrhythmias and is associated with only a low risk if properly employed. In symptomatic patients, the utilization of cardioversion reduces patient discomfort and complications which may occur while awaiting pharmacologic reversion of arrhythmia. At present, transthoracic defibrillation is the only practical method for terminating VF. Despite the safety of electrical reversion, proper precautions are necessary to prevent complications. In particular, the discharge of excessive energies, especially in the presence of digitalis toxicity, promises grave and life-threatening consequences. The use of antiarrhythmic medications is not supplanted by cardioversion and defibrillation. Rather, ongoing drug therapy is frequently necessary to prevent recurrence of arrhythmia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004155     DOI: 10.1016/0002-8703(80)90071-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  20 in total

1.  External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements.

Authors:  G L Botto; A Politi; W Bonini; T Broffoni; R Bonatti
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 2.  Anaesthesia outside the operating room.

Authors:  P H Manninen
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

3.  eHEART: www.heartjnl.com.

Authors: 
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 4.  Pregnancy in patients with implantable cardiac defibrillators.

Authors:  Geoffrey R Wong; Megan Ang; Jasveer Jayarajan; Fiona Walker; Pier D Lambiase
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-05-10

5.  Cardioversion: past, present, and future.

Authors:  Ivan Cakulev; Igor R Efimov; Albert L Waldo
Journal:  Circulation       Date:  2009-10-20       Impact factor: 29.690

6.  Complications of chest thump for termination of supraventricular tachycardia in children.

Authors:  G I Müller; H E Ulmer; J A Bauer
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

Review 7.  Treatment of cardiac arrhythmias during pregnancy: safety considerations.

Authors:  J A Joglar; R L Page
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 8.  Sudden cardiac death--historical perspectives.

Authors:  S P Abhilash; Narayanan Namboodiri
Journal:  Indian Heart J       Date:  2014-02-11

Review 9.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

10.  Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.

Authors:  F Bellandi; R P Dabizzi; F Cantini; M D Natale; L Niccoli
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.